Skip to main content

NRC Health

NRC
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0000070487

No open-market purchases or sales by NRC Health insiders were filed in the last 90 days; 123 institutions reported holding it in 13F filings for Q2 2026, worth $231.9M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding NRC Health changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of NRC: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders109113+4
Shares11.2M11.4M+188.3K (+1.7%)
Value$473.7M$473.7M−$34.3K (0.0%)

New holders (18)

Institutions that held NRC Health at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to NRC in Q4 2021
InstitutionSharesValue% of portfolio
Alpine Peaks Capital, LP79,150$3.29M3.23%
Gsa Capital Partners LLP15,355$638.0K0.08%
Exchange Traded Concepts, LLC12,975$539.0K0.01%
Qube Research & Technologies Ltd8,897$369.0K0.00%
Trexquant Investment LP6,299$262.0K0.02%
Cubist Systematic Strategies, LLC6,249$259.0K0.00%
Jane Street Group, LLC6,202$258.0K0.00%
Jump Financial, LLC5,900$245.0K0.02%
SkyOak Wealth, LLC5,137$213.0K0.05%
Man Group plc5,092$211.0K0.00%
Marshall Wace, LLP3,627$151.0K0.00%
Point72 Hong Kong Ltd301$12.0K0.00%
Allworth Financial LP195$8.00K0.00%
KB Financial Partners, LLC170$7.00K0.00%
Reilly Financial Advisors, LLC113$5.00K0.00%
Covestor Ltd26$1.00K0.00%
Meeder Asset Management Inc1$00.00%
Parallel Advisors, LLC11$00.00%

Sold out (14)

Institutions that held NRC Health at the end of Q3 2021 and filed for Q4 2021 without it.